Back to Journals » ClinicoEconomics and Outcomes Research » Volume 9
Corrigendum
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial [Corrigendum]
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
7,048 | Dovepress* | 6,944+ | 1,425 | 8,369 | |
PubMed Central* | 104 | 50 | 154 | ||
Totals | 7,048 | 1,475 | 8,523 | ||
*Since 19 April 2017 |
View citations on PubMed Central and Google Scholar